TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6412733

Group type: EXPERIMENTAL
Intervention: Alaproclate alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alaproclate combined with morphine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Morphine i.v.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30516574

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Mirtazapine (30 mg/d)
Number of subjects: 112
Study: 29726282

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges containing Lactobacillus reuteri
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 26198895

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 248

Group type: COMPARATOR
Intervention: Conventional monopolar electrosurgery
Number of subjects: 248
Study: 24536008

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SLC)
Number of subjects: 117
Study: 23224449

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 22
Study: 19944452

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with paclitaxel and carboplatin (58% underwent three cycles, 42% had six cycles)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with paclitaxel and carboplatin
Number of subjects: 74
Study: 17442119

Group type: EXPERIMENTAL
Intervention: Calf muscle stretching and sham ultrasound (n = 46)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham ultrasound alone (n = 46)
Number of subjects: 92
Study: 16082607

Group type: EXPERIMENTAL
Intervention: Mini-dose aprotinin (500.000 KIU [70 mg] in the pump)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 86
Study: 11852741

Group type: EXPERIMENTAL
Intervention: 6-week problem-solving diabetes education program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 53
Study: 10223359

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis with 2 g cefotaxime
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis with 4g piperacillin plus 0.5g tazobactam
Number of subjects: 347

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 347
Study: 7495071

Group type: EXPERIMENTAL
Intervention: Dalteparin 2,500 IU
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nadroparin 7,500 IU
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enoxaparin 20 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg
Number of subjects: 20
Study: 2086399

Group type: EXPERIMENTAL
Intervention: Intraocular lens (IOL) with laser ridge
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intraocular lens (IOL) without laser ridge
Number of subjects: 100
Study: 31529385

Group type: EXPERIMENTAL
Intervention: CR + TM
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: TM alone
Number of subjects: 56

Group type: COMPARATOR
Intervention: CR alone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combined TM group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Combined non-TM group
Number of subjects: 56
Study: 30908813

Group type: EXPERIMENTAL
Intervention: STN-DBS ON
Number of subjects: 16

Group type: COMPARATOR
Intervention: STN-DBS OFF
Number of subjects: 16
Study: 29554516

Group type: EXPERIMENTAL
Intervention: Early functional rehabilitation (EFR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional rehabilitation (CR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: All patients (EFR and CR)
Number of subjects: 14
Study: 26829661

Group type: EXPERIMENTAL
Intervention: Tenofovir Alafenamide (TAF)
Number of subjects: 1733

Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF)
Number of subjects: 1733
Study: 25103026

Group type: EXPERIMENTAL
Intervention: Anodal TDCS (2 mA, 30 min) applied to the cerebellum during PASvar360p (360 electrical stimuli of the right median nerve paired with TMS at ISIs of 25 ms and 21.5 ms)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham TDCS applied to the cerebellum during PASvar360p
Number of subjects: 24
Study: 21997545

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin with colonoscopy screening
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin with sigmoidoscopy screening
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Combination of aspirin with colonoscopy and sigmoidoscopy
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Increased proximal CRC prevention rate with colonoscopy
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Probabilistic analysis
Number of subjects: 100000
Study: 20439824

Group type: EXPERIMENTAL
Intervention: Cognitive enhancement therapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Enriched supportive therapy
Number of subjects: 53
Study: 18078406

Group type: EXPERIMENTAL
Intervention: Undershirts coated with borage oil (for 2 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-coated undershirts (placebo)
Number of subjects: 32
Study: 16234012

Group type: EXPERIMENTAL
Intervention: 50 mug IFN-gamma intramuscularly daily for 3 months and on alternate days for the subsequent 6 months
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: IFN-gamma group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study: 12399271

Group type: EXPERIMENTAL
Intervention: 100 g almonds/d for 4 wk
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-fat, high-almond diet (HFA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: High-fat control diet (HFC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-fat, high-almond diet (LFA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-fat control diet (LFC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Almond diets
Number of subjects: 50
Study: 10196648

Group type: EXPERIMENTAL
Intervention: Oral pseudoephedrine (60 mg capsule)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 8561098

Group type: EXPERIMENTAL
Intervention: Mazindol
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 2177062

Group type: EXPERIMENTAL
Intervention: Lisinopril (10, 20, and 40 mg once-daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Captopril (25, 50, and 100 mg twice-daily)
Number of subjects: 70
Study: 389483

Group type: EXPERIMENTAL
Intervention: Diphenylhydantoin (DPH) therapy for 2 years
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no DPH therapy)
Number of subjects: 36
Study: 30238239

Group type: EXPERIMENTAL
Intervention: Early stage periarticular injection (just prior to arthrotomy)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Late stage periarticular injection (after implanting the prosthesis)
Number of subjects: 105
Study: 25439631

Group type: EXPERIMENTAL
Intervention: Occlusal splint
Number of subjects: 30

Group type: COMPARATOR
Intervention: Modified nociceptive trigeminal inhibition splint
Number of subjects: 30
Study: 23820052

Group type: EXPERIMENTAL
Intervention: Magnetic seizure therapy (MST)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 7
Study: 21459271

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin for median duration of 28 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 19632099

Group type: EXPERIMENTAL
Intervention: Atorvastatin (n=22)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Fenofibrate (n=26)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 199
Study: 17565514

Group type: EXPERIMENTAL
Intervention: 1.5% lidocaine (Group L)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (Group R)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 45
Study: 15581045

Group type: EXPERIMENTAL
Intervention: Paclitaxel-gemcitabine-trastuzumab (TGH) regimen: paclitaxel 80 mg/m2/week, gemcitabine 1000 mg/m2 every 2 weeks, trastuzumab 4 mg/kg loading dose then 2 mg/kg/week for 12 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Toxicity assessment
Number of subjects: 40
Study: 11377362

Group type: EXPERIMENTAL
Intervention: New computer algorithm for real-time quantification of electrocardiographic differences
Number of subjects: 0
Study: 9693894

Group type: EXPERIMENTAL
Intervention: Interpleural bupivacaine blockade (n = 43)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard procedure (control group)
Number of subjects: 90
Study: 8164030

Group type: EXPERIMENTAL
Intervention: rHuEPO (100 U/kg body weight subcutaneously) three times per week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 100
Study: 3221746

Group type: EXPERIMENTAL
Intervention: Droxicam 20 mg/day for 20 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piroxicam 20 mg/day for 20 days
Number of subjects: 0
Study: 29941861

Group type: EXPERIMENTAL
Intervention: 1% lidocaine HCl with epinephrine (LL group)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Topical lidocaine spray (TL group)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: 1 mg/kg/h lidocaine infusion (GL group)
Number of subjects: 381
Study: 29017479

Group type: EXPERIMENTAL
Intervention: Workplace physical exercise (WORK) performed in groups during working hours for 10 min 5 days per week
Number of subjects: 200

Group type: COMPARATOR
Intervention: Home-based physical exercise (HOME) performed alone during leisure time for 10 min 5 days per week
Number of subjects: 200
Study: 26300237

Group type: EXPERIMENTAL
Intervention: Weight reduction intervention followed by diet and exercise counselling over 32 months
Number of subjects: 67
Study: 23163416

Group type: EXPERIMENTAL
Intervention: Depletion group (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nondepletion control group (control)
Number of subjects: 0
Study: 21569186

Group type: EXPERIMENTAL
Intervention: Quick-release bromocriptine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18285535

Group type: EXPERIMENTAL
Intervention: Levetiracetam 3,000 mg/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 16569746

Group type: EXPERIMENTAL
Intervention: Propofol (younger than 65 years)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Midazolam (younger than 65 years)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Propofol (65 years and older)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Midazolam (65 years and older)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Midazolam (both age groups)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Propofol (both age groups)
Number of subjects: 70
Study: 15290665

Group type: EXPERIMENTAL
Intervention: Somatostatin (750 microg; n = 351)
Number of subjects: 1127

Group type: EXPERIMENTAL
Intervention: Gabexate mesylate (500 mg; n = 381)
Number of subjects: 1127

Group type: COMPARATOR
Intervention: Placebo (saline; n = 395)
Number of subjects: 1127
Study: 11763977

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 microg q.i.d. after 200 microg intravaginal misoprostol for 5 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Surgical curettage
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Misoprostol and Surgical curettage
Number of subjects: 80
Study: 9313755

Group type: EXPERIMENTAL
Intervention: Factor analysis of fasting and 2-h postchallenge insulin levels, fasting triglyceride and HDL cholesterol levels, BMI, and waist-to-hip ratio.
Number of subjects: 2458

Group type: EXPERIMENTAL
Intervention: Factor analysis of fasting and 2-h levels of glucose and insulin.
Number of subjects: 2458

Group type: EXPERIMENTAL
Intervention: Factor analysis of systolic blood pressure, diastolic blood pressure, and BMI.
Number of subjects: 2458
Study: 7963427

Group type: EXPERIMENTAL
Intervention: Octreotide (200 micrograms)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 3316152

Group type: EXPERIMENTAL
Intervention: Norfloxacin 200 mg bid
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 31119822

Group type: EXPERIMENTAL
Intervention: Compassion-focused therapy (CFT)
Number of subjects: 87
Study: 28889225

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR, cuff pressure 20 mmHG below individual occlusion pressure)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR)
Number of subjects: 20
Study: 27173030

Group type: EXPERIMENTAL
Intervention: Reduced cardiac index (CI)
Number of subjects: 575
Study: 24155069

Group type: EXPERIMENTAL
Intervention: Acupuncture (random acupuncture group, 24 cases)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Acupuncture (non-random acupuncture group, 19 cases)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combined acupuncture group (43 cases)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Guided rehabilitation (guided rehabilitation group, 24 cases)
Number of subjects: 63
Study: 22701334

Group type: EXPERIMENTAL
Intervention: Active exercises using a facilitating device with a compression sleeve
Number of subjects: 20

Group type: COMPARATOR
Intervention: Active exercises using a facilitating device without a compression sleeve
Number of subjects: 20
Study: 20976768

Group type: EXPERIMENTAL
Intervention: Dalfampridine (10mg twice daily)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study: 18415896

Group type: EXPERIMENTAL
Intervention: Colonic pouch anastomosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Colonic J pouch (6-cm length)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coloplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ileocecal pouch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse double stapling technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nerve-sparing mesorectal excision
Number of subjects: 0
Study: 16841342

Group type: EXPERIMENTAL
Intervention: Short PTSD Rating Interview (SPRINT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinician‐Administered PTSD Scale for DSM‐IV (CAPS)
Number of subjects: 0
Study: 12515870

Group type: EXPERIMENTAL
Intervention: 99mTc-sulesomab
Number of subjects: 7

Group type: COMPARATOR
Intervention: 99mTc-HSA
Number of subjects: 7

Group type: COMPARATOR
Intervention: (111)In-leukocytes
Number of subjects: 7
Study: 10332907

Group type: EXPERIMENTAL
Intervention: Women's Safety in Recovery group (N=48), met three times weekly for one hour
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment as usual (N=38)
Number of subjects: 86
Study: 7673041

Group type: EXPERIMENTAL
Intervention: Five fractions per week
Number of subjects: 1345

Group type: COMPARATOR
Intervention: Three fractions per week
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Short overall time (<= 4 weeks)
Number of subjects: 1345

Group type: COMPARATOR
Intervention: Long overall time (4-7 weeks)
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Acute normal-tissue effects
Number of subjects: 1345

Group type: EXPERIMENTAL
Intervention: Late complications
Number of subjects: 1345
Study: 2767906

Group type: EXPERIMENTAL
Intervention: Teaching intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Written material intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 150
Study: 1097344

Group type: EXPERIMENTAL
Intervention: beta-amino-isobutyl-benzol as polysterol-sulfonate
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 30547267

Group type: EXPERIMENTAL
Intervention: pH-neutral solutions
Number of subjects: 127

Group type: COMPARATOR
Intervention: Conventional solutions
Number of subjects: 127
Study: 28384480

Group type: EXPERIMENTAL
Intervention: L-Tyrosine administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral tDCS over DLPFC with L-Tyrosine
Number of subjects: 0
Study: 25738670

Group type: EXPERIMENTAL
Intervention: VR-CAP (R-CHOP regimen with bortezomib at a dose of 1.3 mg/m² on days 1, 4, 8, and 11)
Number of subjects: 487

Group type: COMPARATOR
Intervention: R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: VR-CAP
Number of subjects: 487

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 487
Study: 23921656

Group type: EXPERIMENTAL
Intervention: Licorice gargle (Extractum Liquiritiae Fluidum, 0.5 g in 30 mL water)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Sugar-water gargle (Sirupus Simplex, 5 g in 30 mL water)
Number of subjects: 236
Study: 20673585

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G‐CSF) as an adjunct to de novo AML remission induction therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G‐CSF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no G‐CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single induction cycle
Number of subjects: 0
Study: 19463464

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 146

Group type: COMPARATOR
Intervention: Ioxaglate
Number of subjects: 146
Study: 17716311

Group type: EXPERIMENTAL
Intervention: Split-mouth design studies
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Statistical methods used in studies
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sample size calculation
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Survival analysis
Number of subjects: 34
Study: 15086539

Group type: EXPERIMENTAL
Intervention: Misoprostol (0.4‐0.8 mg per day) for 6 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Misoprostol treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy control subjects (n=11)
Number of subjects: 21
Study: 11473954

Group type: EXPERIMENTAL
Intervention: Oral HRT (2 mg oestradiol on days 1‐‐12, 2 mg oestradiol plus 1 mg norethisterone acetate (NETA) on days 13‐‐22, and 1 mg oestradiol on days 23‐‐28, n = 19)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50 microg/day of oestradiol on days 1‐‐13, and 50 microg oestradiol plus 250 microg/day NETA on days 14‐‐28, n = 19)
Number of subjects: 38
Study: 9777880

Group type: EXPERIMENTAL
Intervention: Asthma education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: AGKQA
Number of subjects: 0
Study: 8052367

Group type: EXPERIMENTAL
Intervention: Intermittent administration of 0.75 microgram calcitriol twice weekly (total weekly dose of 5.25 micrograms)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Continuous administration of 0.75 microgram calcitriol daily (total weekly dose of 5.25 micrograms)
Number of subjects: 45
Study: 3524067

Group type: EXPERIMENTAL
Intervention: Pirprofen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 0
Study: 31831276

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no HBOT)
Number of subjects: 25
Study: 29205158

Group type: EXPERIMENTAL
Intervention: Chronic total occlusion (CTO) in a non-infarct-related artery
Number of subjects: 761
Study: 27528049

Group type: EXPERIMENTAL
Intervention: Nurse-led community-based self-management programme plus usual care
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 23839004

Group type: EXPERIMENTAL
Intervention: 21G micropuncture needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: 19G access needle
Number of subjects: 100
Study: 22879899

Group type: EXPERIMENTAL
Intervention: Combination antiretroviral therapy (cART)
Number of subjects: 166
Study: 20688442

Group type: EXPERIMENTAL
Intervention: 0.5 mg 17β-oestradiol/2.5 mg dydrogesterone (E 0.5 mg/D 2.5 mg)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: 1 mg 17β-oestradiol/5 mg dydrogesterone (E 1mg/D 5 mg)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: E 0.5 mg/D 2.5 mg
Number of subjects: 313
Study: 18950303

Group type: EXPERIMENTAL
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 153
Study: 18245764

Group type: EXPERIMENTAL
Intervention: Square-stepping exercise (SSE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Walking (W)
Number of subjects: 68
Study: 15196155

Group type: EXPERIMENTAL
Intervention: Intramuscular penicillin (2 MU x 2 times daily)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Intravenous benzyl penicillin (4 MU x 6 times daily)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Intravenous benzyl penicillin
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Intramuscular penicillin
Number of subjects: 112
Study: 11604648

Group type: EXPERIMENTAL
Intervention: CO2 laser (two applications)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Erbium laser (two applications)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Erbium laser (one application)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CO2 laser (one application) + Erbium laser (one application)
Number of subjects: 10
Study: 9405029

Group type: EXPERIMENTAL
Intervention: HRT (sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: Vit D3 (vitamin D3 300 IU/day)
Number of subjects: 464

Group type: EXPERIMENTAL
Intervention: HRT+Vit D3 (both as above)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo (calcium lactate 500 mg/day)
Number of subjects: 464
Study: 2873324

Group type: EXPERIMENTAL
Intervention: Interval cancers (94 patients)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control patients (178 patients)
Number of subjects: 272
Study: 31292219

Group type: EXPERIMENTAL
Intervention: Educational handout about influenza disease (local data)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Educational handout about influenza disease (national data)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0